Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Liquidia Corporation(LQDA) | 2,545,000 | 2,447,500 | -97,500 | $88.82M | $195.14M | 17.67% | +$106.32M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,860,000 | 2,860,000 | 0 | $70.58M | $103.53M | 9.38% | +$32.95M |
| Harrow, Inc.(HROW) | 2,832,230 | 2,400,000 | -432,230 | $99.86M | $101.93M | 9.23% | +$2.06M |
| Disc Medicine, Inc.(IRON) | 421,000 | 855,000 | +434,000 | $26.92M | $62.53M | 5.66% | +$35.62M |
| UroGen Pharma Ltd.(URGN) | 1,430,000 | 1,439,996 | +9,996 | $25.71M | $52.99M | 4.80% | +$27.28M |
| Apogee Therapeutics Inc | 390,000 | 390,000 | 0 | $32.83M | $51.76M | 4.69% | +$18.94M |
| MeiraGTx Holdings plc(MGTX) | 2,123,259 | 3,550,000 | +1,426,741 | $18.39M | $47.96M | 4.34% | +$29.57M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 500,000 | 500,000 | 0 | $39.61M | $37.07M | 3.36% | -$2.54M |
| Rezolute, Inc.(RZLT) | 6,300,000 | 6,300,000 | 0 | $19.21M | $32.76M | 2.97% | +$13.54M |
| TG Therapeutics, Inc.(TGTX) | 535,000 | 535,000 | 0 | $17.77M | $29.39M | 2.66% | +$11.62M |
| Immix Biopharma, Inc.(IMMX) | 0 | 2,345,000 | +2,345,000 | $0 | $24.18M | 2.19% | +$24.18M |
| Crescent Biopharma, Inc.(CBIO) | 1,312,615 | 1,319,351 | +6,736 | $24.11M | $23.75M | 2.15% | -$364.4K |
| Stoke Therapeutics, Inc.(STOK) | 700,000 | 700,000 | 0 | $22.79M | $22.90M | 2.07% | +$112.0K |
| Alpha Cognition Inc. Common Stock(ACOG) | 2,561,950 | 2,895,467 | +333,517 | $14.07M | $20.91M | 1.89% | +$6.84M |
| Edgewise Therapeutics, Inc.(EWTX) | 500,000 | 500,000 | 0 | $15.75M | $20.32M | 1.84% | +$4.57M |
| Revolution Medicines, Inc.(RVMD) | 100,000 | 100,000 | 0 | $9.72M | $18.73M | 1.70% | +$9.00M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 745,000 | +745,000 | $0 | $18.03M | 1.63% | +$18.03M |
| Alumis Inc | 550,000 | 550,000 | 0 | $12.12M | $15.48M | 1.40% | +$3.36M |
| Codexis, Inc.(CDXS) | 6,785,000 | 6,785,000 | 0 | $11.06M | $15.33M | 1.39% | +$4.27M |
| Replimune Group, Inc.(REPL) | 0 | 1,384,993 | +1,384,993 | $0 | $15.33M | 1.39% | +$15.33M |
| Xoma Royalty Corporation | 300,000 | 338,374 | +38,374 | $9.41M | $14.38M | 1.30% | +$4.97M |
| MBX Biosciences, Inc.(MBX) | 260,000 | 260,000 | 0 | $7.76M | $14.35M | 1.30% | +$6.59M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 123,000 | 122,500 | -500 | $35.32M | $13.60M | 1.23% | -$21.72M |
| Editas Medicine, Inc.(EDIT) | 1,926,997 | 3,861,930 | +1,934,933 | $4.76M | $12.51M | 1.13% | +$7.75M |
| Protagonist Therapeutics Inc | 100,000 | 100,000 | 0 | $10.54M | $12.26M | 1.11% | +$1.72M |
| Cabaletta Bio, Inc.(CABA) | 1,380,000 | 3,863,800 | +2,483,800 | $3.71M | $12.02M | 1.09% | +$8.30M |
| Q32 Bio Inc.(QTTB) | 1,256,228 | 931,000 | -325,228 | $8.06M | $11.86M | 1.07% | +$3.80M |
| Annexon, Inc.(ANNX) | 2,331,761 | 1,714,451 | -617,310 | $12.92M | $9.79M | 0.89% | -$3.13M |
| Verastem, Inc.(VSTM) | 0 | 1,800,000 | +1,800,000 | $0 | $6.88M | 0.62% | +$6.88M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,412,656 | 1,412,656 | 0 | $3.31M | $6.85M | 0.62% | +$3.55M |
| Relmada Therapeutics, Inc.(RLMD) | 935,000 | 935,000 | 0 | $6.51M | $6.47M | 0.59% | -$37.4K |
| Ocular Therapeutix, Inc.(OCUL) | 600,000 | 600,000 | 0 | $5.08M | $5.89M | 0.53% | +$810.0K |
| Trevi Therapeutics, Inc.(TRVI) | 345,100 | 310,000 | -35,100 | $4.12M | $5.78M | 0.52% | +$1.66M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 53,282 | 700,000 | +646,718 | $476.9K | $5.33M | 0.48% | +$4.86M |
| Lyell Immunopharma, Inc.(LYEL) | 79,097 | 344,025 | +264,928 | $1.59M | $4.83M | 0.44% | +$3.25M |
| Opus Genetics, Inc.(IRD) | 1,120,000 | 1,125,000 | +5,000 | $2.25M | $4.62M | 0.42% | +$2.37M |
| 4d Molecular Therapeutics In | 112,291 | 334,437 | +222,146 | $1.05M | $4.45M | 0.40% | +$3.40M |
| Intellia Therapeutics, Inc.(NTLA) | 245,000 | 250,000 | +5,000 | $3.14M | $4.23M | 0.38% | +$1.09M |
| Voyager Therapeutics, Inc.(VYGR) | 1,150,000 | 1,185,000 | +35,000 | $4.44M | $4.15M | 0.38% | -$291.5K |
| Biodesix, Inc.(BDSX) | 238,047 | 180,000 | -58,047 | $3.45M | $4.06M | 0.37% | +$607.3K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 955,000 | 1,000,000 | +45,000 | $3.42M | $3.42M | 0.31% | +$1.1K |
| Jade Biosciences Inc | 427,608 | 145,000 | -282,608 | $6.01M | $3.22M | 0.29% | -$2.79M |
| SANUWAVE Health, Inc.(SNWV) | 981,267 | 306,140 | -675,127 | $16.97M | $3.06M | 0.28% | -$13.90M |
| Fortress Biotech, Inc.(FBIO) | 1,042,000 | 890,000 | -152,000 | $2.91M | $2.72M | 0.25% | -$183.8K |
| Journey Medical Corporation(DERM) | 960,000 | 350,000 | -610,000 | $4.50M | $2.48M | 0.22% | -$2.02M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 185,589 | +185,589 | $0 | $2.01M | 0.18% | +$2.01M |
| Inhibrx Biosciences, Inc.(INBX) | 0 | 20,291 | +20,291 | $0 | $1.92M | 0.17% | +$1.92M |
| Enanta Pharmaceuticals, Inc.(ENTA) | 125,000 | 125,000 | 0 | $1.58M | $1.82M | 0.17% | +$243.8K |
| Hemab Therapeutics Hldgs Inc | 0 | 47,652 | +47,652 | $0 | $1.75M | 0.16% | +$1.75M |
| First Tracks Biotherapeutics | 0 | 65,000 | +65,000 | $0 | $1.31M | 0.12% | +$1.31M |
| CG Oncology, Inc.(CGON) | 94,800 | 17,789 | -77,011 | $6.42M | $1.26M | 0.11% | -$5.15M |
| Biohaven Ltd.(BHVN) | 0 | 77,915 | +77,915 | $0 | $1.16M | 0.10% | +$1.16M |
| Atea Pharmaceuticals, Inc.(AVIR) | 322,600 | 235,000 | -87,600 | $1.74M | $1.09M | 0.10% | -$642.8K |
| Pasithea Therapeutics Corp.(KTTA) | 0 | 2,050,000 | +2,050,000 | $0 | $1.06M | 0.10% | +$1.06M |
| ADC Therapeutics SASHS(ADCT) | 0 | 700,000 | +700,000 | $0 | $749.0K | 0.07% | +$749.0K |
| OKYO Pharma LimitedSHS NEW(OKYO) | 0 | 375,204 | +375,204 | $0 | $562.8K | 0.05% | +$562.8K |
| Palatin Technologies, Inc.(PTN) | 0 | 20,500 | +20,500 | $0 | $221.2K | 0.02% | +$221.2K |
| Adagio Medical Holdings, Inc.(ADGM) | 18,444 | 18,444 | 0 | $21.2K | $13.4K | 0.00% | -$7.9K |
| Assertio Holdings Inc | 265,707 | 0 | -265,707 | $5.06M | $0 | — | -$5.06M |
| LB Pharmaceuticals Inc(LBRX) | 14,506 | 0 | -14,506 | $357.7K | $0 | — | -$357.7K |
| Nextcure Inc | 141,181 | 0 | -141,181 | $1.51M | $0 | — | -$1.51M |
| Perspective Therapeutics, Inc.(CATX) | 4,675,000 | 0 | -4,675,000 | $19.49M | $0 | — | -$19.49M |
| Perspective Therapeutics, Inc.CALL(CATX) | 200,000 | 0 | -200,000 | $834.0K | $0 | — | -$834.0K |
| Protalix BioTherapeutics, Inc.(PLX) | 340,000 | 0 | -340,000 | $737.8K | $0 | — | -$737.8K |
| Rigel Pharmaceuticals, Inc.(RIGL) | 70,000 | 0 | -70,000 | $1.89M | $0 | — | -$1.89M |
| Sutro Biopharma, Inc.(STRO) | 190,671 | 0 | -190,671 | $4.75M | $0 | — | -$4.75M |
| Tectonic Therapeutic, Inc.(TECX) | 123,000 | 0 | -123,000 | $3.80M | $0 | — | -$3.80M |